7-15366181-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004320.2(AGMO):āc.1116T>Gā(p.Ile372Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,609,330 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I372V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001004320.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AGMO | NM_001004320.2 | c.1116T>G | p.Ile372Met | missense_variant | 11/13 | ENST00000342526.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AGMO | ENST00000342526.8 | c.1116T>G | p.Ile372Met | missense_variant | 11/13 | 1 | NM_001004320.2 | P1 | |
AGMO | ENST00000407277.6 | c.9T>G | p.Ile3Met | missense_variant | 1/3 | 3 | |||
AGMO | ENST00000418075.1 | c.42T>G | p.Ile14Met | missense_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000163 AC: 4AN: 245294Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132516
GnomAD4 exome AF: 0.0000213 AC: 31AN: 1457200Hom.: 0 Cov.: 30 AF XY: 0.0000221 AC XY: 16AN XY: 724626
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 13, 2023 | The c.1116T>G (p.I372M) alteration is located in exon 11 (coding exon 11) of the AGMO gene. This alteration results from a T to G substitution at nucleotide position 1116, causing the isoleucine (I) at amino acid position 372 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at